HIGHLIGHTS
- who: Yashavantha L. Vishweshwaraiah and Nikolay V. Dokholyan from the Shenzhen Institute of Advanced Technology (CAS), China Duke University, United States have published the research work: mRNA vaccines for cancer immunotherapy, in the Journal: (JOURNAL)
- what: Finding effective means to fight cancer has been one of the main goals of researchers worldwide for decades and still presents the authors with enormous challenges. For this review, the authors focus only on mRNA-based vaccines. humoral and cellular immune_responses, relatively low production cost, and ease of manufacturing .
- future: Future studies could focus on combining mRNA . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.